Ahead of its annual general meeting in May 2027, Sobi's nomination committee has announced its proposed new chair. The ...

Eli Lilly is discontinuing development of its Alzheimer’s drug candidate mevidalen. The decision follows a phase II trial ...

AstraZeneca beat market expectations in the third quarter. At the same time, the company announced a cost-cutting programme ...

Ferring has signed an agreement to acquire US biotechnology company Gameto in a deal worth up to $1.4 billion.

SynAct Pharma has entered into its first commercial partnership for resomelagon as a potential treatment for dengue fever.

MEMBER ANNOUNCEMENT - New welding solution aims to increase capacity and ensure quality in flip-off cap production ...

Two multibillion-dollar deals, the company’s first profit and an oversubscribed share issue. After an eventful year, AlzeCure ...

Medical breakthroughs have transformed healthcare, but scientific progress alone is not enough. As misinformation spreads and ...

A single tumour DNA molecule among more than a million others. That is how small a trace of cancer Abbott’s upgraded ...

AstraZeneca is considering developing cancer vaccines based on mRNA technology, CEO Pascal Soriot said at a conference on ...

Danish biotech company ResoTher Pharma, which is developing drugs to treat heart conditions, plans to list on the Swedish ...

AstraZeneca’s Enhertu is moving into earlier-stage breast cancer treatment after winning EU approval. In a phase III trial, ...